Clinical Trials Browser

Phase 2 × Thymoma × pembrolizumab × Clear all

NCT03463460 2025-08-24

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Phase 2 Recruiting

Thymoma

NCT05832827 2023-10-23

Artemis

Phase 2 Recruiting

Thymoma

NCT02364076 2019-12-13

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Phase 2 Unknown

45 enrolled 10 charts

Thymoma, Thymus Neoplasms